EC
CYCN icon

EcoR1 Capital’s Cyclerion Therapeutics CYCN Stock Holding History

EcoR1 Capital’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-80,314
Closed -$4.93M – 82
2021
Q3 		$4.93M Hold
80,314
– – 0.17% 42
2021
Q2 		$6.26M Hold
80,314
– – 0.23% 39
2021
Q1 		$4.48M Hold
80,314
– – 0.2% 43
2020
Q4 		$4.92M Sell
80,314
-56,800
-41% -$3.87M 0.27% 41
2020
Q3 		$16.7M Hold
137,114
– – 1.2% 21
2020
Q2 		$16.2M Hold
137,114
– – 1.21% 23
2020
Q1 		$7.27M Buy
137,114
+46,564
+51% +$3.32M 0.76% 31
2019
Q4 		$4.93M Buy
90,550
+51,740
+133% +$4.83M 0.47% 35
2019
Q3 		$9.41M Hold
38,810
– – 1.26% 20
2019
Q2 		$8.89M Buy
+38,810
New +$11M 0.92% 22

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return